Cargando…
Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
A perspective overview is given describing the current development of multiplex mass spectrometry assay technology platforms utilized for high throughput clinical sample analysis. The development of targeted therapies with novel personalized medicine drugs will require new tools for monitoring effic...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164614/ https://www.ncbi.nlm.nih.gov/pubmed/21884626 http://dx.doi.org/10.1186/2043-9113-1-7 |